By Chris Wack
Phio Pharmaceuticals shares were down 16% to $3.40 after the company said it has agreed to issue and sell 234,000 shares at $4.28 a share in a registered direct offering.
In a concurrent private placement, Phio has also agreed to issue and sell 701,000 shares at $4.28 a share.
The…
Read the full article here
